• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管生成、抗血管生成及血管靶向治疗的最新进展

Recent advances in angiogenesis, anti-angiogenesis and vascular targeting.

作者信息

Bikfalvi Andreas, Bicknell Roy

机构信息

INSERM E 0113 Molecular Mechanisms of Angiogenesis and Growth Factor and Cell Differentiation Laboratory, University Bordeaux I, France.

出版信息

Trends Pharmacol Sci. 2002 Dec;23(12):576-82. doi: 10.1016/s0165-6147(02)02109-0.

DOI:10.1016/s0165-6147(02)02109-0
PMID:12457776
Abstract

Angiogenesis, the development of new blood vessels, has become a major focus of research. This has been stimulated by the therapeutic opportunities offered by the ability to manipulate the vasculature in pathologies such as cancer. Here, we present an overview of recent advances in angiogenesis. Especially noteworthy is the large volume of information from developmental studies, particularly those that involve transgenic and gene knockout mice. We also discuss the increasing repertoire of drugs with which to manipulate angiogenesis and new endothelial-specific genes with which to target the vasculature.

摘要

血管生成,即新血管的形成,已成为研究的主要焦点。这是受到了在癌症等病理学中操控脉管系统所带来的治疗机遇的刺激。在此,我们概述血管生成方面的最新进展。特别值得注意的是来自发育研究的大量信息,尤其是那些涉及转基因和基因敲除小鼠的研究。我们还讨论了用于操控血管生成的药物种类不断增加,以及用于靶向脉管系统的新的内皮细胞特异性基因。

相似文献

1
Recent advances in angiogenesis, anti-angiogenesis and vascular targeting.血管生成、抗血管生成及血管靶向治疗的最新进展
Trends Pharmacol Sci. 2002 Dec;23(12):576-82. doi: 10.1016/s0165-6147(02)02109-0.
2
Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.血管内皮生长因子在生理性和病理性血管生成中的作用:治疗意义
Semin Oncol. 2002 Dec;29(6 Suppl 16):10-4. doi: 10.1053/sonc.2002.37264.
3
Imaging tumor angiogenesis.肿瘤血管生成成像
J Clin Invest. 2006 Oct;116(10):2585-7. doi: 10.1172/JCI30058.
4
Promises and pitfalls of anti-angiogenic therapy in clinical trials.临床试验中抗血管生成疗法的前景与隐患
Trends Mol Med. 2003 Feb;9(2):53-8. doi: 10.1016/s1471-4914(03)00002-9.
5
Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?血管和造血干细胞:抗血管生成治疗的新靶点?
Nat Rev Cancer. 2002 Nov;2(11):826-35. doi: 10.1038/nrc925.
6
Vascular endothelial growth factor as a target for antiangiogenic therapy.血管内皮生长因子作为抗血管生成治疗的靶点。
J Clin Oncol. 2000 Nov 1;18(21 Suppl):45S-6S.
7
[Neoplasms and angiogenesis].[肿瘤与血管生成]
Pol Merkur Lekarski. 2002 Sep;13(75):225-8.
8
Manipulating Angiogenesis by Targeting Endothelial Metabolism: Hitting the Engine Rather than the Drivers-A New Perspective?通过靶向内皮细胞代谢来调控血管生成:直击引擎而非驱动因素——新视角?
Pharmacol Rev. 2016 Jul;68(3):872-87. doi: 10.1124/pr.116.012492.
9
[Significance of vascular endothelial growth factor--VEGF--in tumor angiogenesis. Therapeutic possibilities in solid tumors].[血管内皮生长因子——VEGF——在肿瘤血管生成中的意义。实体瘤的治疗可能性]
Ugeskr Laeger. 2000 Sep 11;162(37):4916-20.
10
Anticancer therapy with angiogenesis inhibitors.使用血管生成抑制剂的抗癌疗法。
Tumori. 2001 Nov-Dec;87(6):S14-6.

引用本文的文献

1
Recent Advances in Propranolol Hydrochloride Formulations for the Treatment of Infantile Hemangiomas.用于治疗婴儿血管瘤的盐酸普萘洛尔制剂的最新进展
Drug Des Devel Ther. 2025 Feb 18;19:1163-1183. doi: 10.2147/DDDT.S496847. eCollection 2025.
2
Standardization to Characterize the Complexity of Vessel Network Using the Aortic Ring Model.使用主动脉环模型对血管网络复杂性进行表征的标准化。
Int J Mol Sci. 2024 Dec 31;26(1):291. doi: 10.3390/ijms26010291.
3
Promotion of mature angiogenesis in ischemic stroke by Taohong Siwu decoction through glycolysis activation.
桃红四物汤通过激活糖酵解促进缺血性脑卒中成熟血管生成
Front Pharmacol. 2024 Jun 18;15:1395167. doi: 10.3389/fphar.2024.1395167. eCollection 2024.
4
Liposomal Drug Delivery Systems for Cancer Therapy: The Rotterdam Experience.用于癌症治疗的脂质体药物递送系统:鹿特丹经验
Pharmaceutics. 2022 Oct 11;14(10):2165. doi: 10.3390/pharmaceutics14102165.
5
A DNA small molecular probe with increasing K concentration promoted selectivity.一种随着钾离子浓度增加而促进选择性的DNA小分子探针。
RSC Adv. 2021 Apr 22;11(25):15030-15035. doi: 10.1039/d0ra06274j. eCollection 2021 Apr 21.
6
Recent Developments in Small-Molecule Ligands of Medicinal Relevance for Harnessing the Anticancer Potential of G-Quadruplexes.小分子配体在医学上的最新进展,以利用 G-四链体的抗癌潜力。
Molecules. 2021 Feb 5;26(4):841. doi: 10.3390/molecules26040841.
7
PPARα ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis.过氧化物酶体增殖物激活受体 α 配体 AVE8134 和环氧化酶抑制剂联合治疗协同抑制肺癌生长和转移。
BMC Cancer. 2019 Dec 2;19(1):1166. doi: 10.1186/s12885-019-6379-5.
8
Immune Complexes Impaired Glomerular Endothelial Cell Functions in Lupus Nephritis.免疫复合物损害狼疮肾炎肾小球内皮细胞功能。
Int J Mol Sci. 2019 Oct 24;20(21):5281. doi: 10.3390/ijms20215281.
9
Tissue Augmentation in Wound Healing: the Role of Endothelial and Epithelial Cells.伤口愈合中的组织增强:内皮细胞和上皮细胞的作用
Med Arch. 2018 Dec;72(6):444-448. doi: 10.5455/medarh.2018.72.444-448.
10
Recent Progress of Targeted G-Quadruplex-Preferred Ligands Toward Cancer Therapy.靶向 G-四链体优先配体在癌症治疗中的最新进展。
Molecules. 2019 Jan 24;24(3):429. doi: 10.3390/molecules24030429.